NCT01857258

Brief Summary

The objective of this study is to formulate and validate a green tea confection (i.e. "gummy" candy) as a strategy to attenuate postprandial hyperglycemia-induced impairments in vascular function. The central hypothesis is that a green tea confection will protect against vascular endothelial dysfunction by suppressing postprandial hyperglycemia. The central hypothesis of this application will be assessed by developing a green tea-containing confection, examining its physiochemical properties and its inhibition of starch digestion, and then validating its vasoprotective activities in healthy humans by assessing its blood glucose-regulating activities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

May 16, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 20, 2013

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
11 months until next milestone

Results Posted

Study results publicly available

February 16, 2017

Completed
Last Updated

February 16, 2017

Status Verified

February 1, 2017

Enrollment Period

1.8 years

First QC Date

May 16, 2013

Results QC Date

September 30, 2016

Last Update Submit

February 14, 2017

Conditions

Keywords

green teacatechinsvascular endothelial functionpostprandial hyperglycemiaoxidative stress

Outcome Measures

Primary Outcomes (4)

  • Area Under the Curve of Blood Glucose

    Blood glucose will be measured at 0, 30, 60, 90, 120, 150 and 180 minutes following the ingestion of a confection to calculate area under the concentration-time curve.

    Area under the Curve, 0, 30, 60, 90, 120, 150, 180 minutes post-dose

  • Area Under the Curve of Brachial Artery Flow Mediated Dilatiion

    Brachial artery flow-mediated dilation will be measured at 0, 30, 60, 90, 120, 150, and 180 minutes following the ingestion of a confection.

    Area under the Curve, 0, 30, 60, 90, 120, 150, 180 minutes post-dose

  • Brachial Artery Flow-mediated Dilation

    0 min (baseline)

  • Brachial Artery Flow-mediated Dilation

    60 min

Secondary Outcomes (4)

  • Malondialdehyde (0 Min)

    Baseline (0 min)

  • Malondialdehyde

    60 min postprandially

  • Ratio of Asymmetric Dimethylarginine Relative to Arginine

    0 min (baseline)

  • Ratio of Asymmetric Dimethylarginine Relative to Arginine

    60 min (baseline)

Study Arms (2)

Green Tea

EXPERIMENTAL

Participants will be provided a confection containing green tea concentrate

Dietary Supplement: Green Tea Concentrate

Control

ACTIVE COMPARATOR

Participants will be provided a confection devoid of green tea concentrate

Dietary Supplement: Green Tea Concentrate

Interventions

Green Tea ConcentrateDIETARY_SUPPLEMENT

Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose

ControlGreen Tea

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Plasma glucose \<100 mg/dL
  • Plasma total cholesterol \<200 mg/dL
  • Plasma triglycerides \<140 mg/dL
  • Blood pressure \<140/90
  • non-dietary supplement user for \>2 months
  • no use of medications known to affect carbohydrate metabolism,
  • nonsmoker / never smoker
  • no history of cardiovascular disease or gastrointestinal disorders

You may not qualify if:

  • allergies or aversions to green tea and/or corn starch,
  • excessive alcohol consumption (\>3 drinks/d),
  • \>5 h/wk of aerobic activity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University

Columbus, Ohio, 43210, United States

Location

Related Publications (1)

  • Sapper TN, Mah E, Ahn-Jarvis J, McDonald JD, Chitchumroonchokchai C, Reverri EJ, Vodovotz Y, Bruno RS. A green tea-containing starch confection increases plasma catechins without protecting against postprandial impairments in vascular function in normoglycemic adults. Food Funct. 2016 Sep 14;7(9):3843-53. doi: 10.1039/c6fo00639f. Epub 2016 Aug 5.

MeSH Terms

Conditions

HyperglycemiaCardiovascular Diseases

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Limitations and Caveats

This study was limited to normoglycemic adults who were healthy. Future studies may consider populations having glucose intolerance to examine the extent to which green tea attenuates starch-induced hyperglycemia.

Results Point of Contact

Title
Richard Bruno, PhD, RD
Organization
The Ohio State University

Study Officials

  • Richard Bruno, PhD, RD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 16, 2013

First Posted

May 20, 2013

Study Start

May 1, 2013

Primary Completion

February 1, 2015

Study Completion

April 1, 2016

Last Updated

February 16, 2017

Results First Posted

February 16, 2017

Record last verified: 2017-02

Data Sharing

IPD Sharing
Will share

Locations